Advertisement: Mogrify mid banner
Advertisement: Simpsons Creative
Barr Ellison Solicitors – commercial property
Advertisement: TTP
Advertisement: RSM
ARM Innovation Hub
Advertisement – Charles Stanley mid banner
RealVNC mid banner careers
Advertisement: Cambridge Network mid banner
Advertisement: EBCam mid banner
Mid banner advertisement: BDO
Advertisement: Kao Data Centre mid banner
Advertisement: Wild Knight Vodka
Advertisement: S-Tech mid banner 3
Advertisement: Hewitsons mid banner
Advertisement: EY Mid banner
CBM light up lives mid banner advert
Advertisement: Howard Group mid banner
10 February, 2021 - 10:05 By Tony Quested

SDI shares soar on trading update

Shares in Cambridge based SDI Group plc opened 27 per cent higher today to 153p after a trading update flagged significantly higher revenues and profit for 2021 and 2022.

The company has indicated that it expects revenues to exceed £34 million in FY 2021 and £42m in FY 2022 and for adjusted pre-tax profit to
exceed £6.7m and £8.7m, respectively. 

The figures imply revenue and adjusted pre-tax profit growth of 24 per cent and 31 per cent, respectively.

SDI Group is focused on the design and manufacture of scientific and technology products for use in digital imaging and sensing and control applications.

Chairman Ken Ford said: “These are exceptional prospective outcomes in unprecedented times, during which the staff across SDI have executed on all aspects of our buy-and-build business model.”

Ford said that while most of SDI’s businesses had seen revenues negatively impacted by the COVID-19 pandemic, two of its businesses secured significant one-time contracts for equipment relating respectively to the treatment and testing of COVID-19 and of similar respiratory and viral diseases.

Ford said: “We are very pleased to report that our Atik Cameras business unit has secured follow-on camera orders from an OEM manufacturer of real time PCR DNA amplifiers with delivery centred on our year to 30 April 2022. 

“This is a significant endorsement of the Atik Camera design and production capability, recognising its expertise in imaging solutions for life sciences.

“While timing of delivery for the orders in hand is still to be finalised, and there is no guarantee that further orders will follow, the board believes that the group, as a whole, will exceed the market’s sales and profit expectations for the year ending 30 April 2021 and substantially exceed the market’s sales and profit expectations for the year ending 30 April 2022.

“This is also underpinned by the continued recovery of activity across all of its businesses.”

Newsletter Subscription

Stay informed of the latest news and features